Clinical Trial Update: Recombinant Influenza Vaccination in U.S. Nursing Homes [Phase 4]

View source ↗

Summary

Phase 4 trial update for a recombinant influenza vaccine studied in U.S. nursing homes; overall status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza-like Illness

Drugs mentioned

• Recombinant Influenza Vaccine

Snippet

Sponsor: Insight Therapeutics, LLC | Conditions: Influenza, Influenza -Like Illness | Phase 4 | Status: UNKNOWN